Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D9RYF5
|
|||
| Drug Name |
INO-3107
|
|||
| Indication | Respiratory papillomatosis [ICD-11: 2F00.1] | Phase 1/2 | [1] | |
| Company |
Inovio Pharmaceuticals Plymouth Meeting, PA
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04398433) An Open-label Multi-center Study of INO-3107 With Electroporation (EP) in Subjects With HPV-6- and/or HPV-11-associated Recurrent Respiratory Papillomatosis (RRP). U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.